12 Information Technology Stocks Moving In Wednesday’s After-Market Session
Gainers Presto Automation (NASDAQ:PRST) shares moved upwards by 33.1% to $0.1 during Wednesday’s after-market session. The company’s market…
12 Information Technology Stocks Moving In Tuesday’s After-Market Session
Gainers SMX (Security Matters) (NASDAQ:SMX) shares rose 45.0% to $0.17 during Tuesday’s after-market session. The company’s market cap…
8 Analysts Have This To Say About Extreme Networks
Extreme Networks (NASDAQ:EXTR) has been analyzed by 8 analysts in the last three months, revealing a diverse range…
Major Indexes Close In The Red, Dow Falls Below 40,000 As Investors Make U-Turn On Economic Outlook
Dow Jones closes 0.1% lower; S&P 500 & Nasdaq 100 fall 0.2%; Mixed data on inflation, jobless claims and housing.
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of Fluent Inc (NASDAQ:FLNT) fell sharply during Thursday’s session after posting weaker-than-expected quarterly results. Fluent posted adjusted…
Walmart Posts Upbeat Earnings, Joins Canada Goose, Lightspeed Commerce And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones gaining over 50 points on Thursday. Shares of Walmart Inc.…
Key Takeaways From Extreme Networks Analyst Ratings
Extreme Networks (NASDAQ:EXTR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from…
Extreme Networks Expects FY24 Net Revenue of $1.1105B-$1.1205B Vs $1.125B Est, Adj EPS of $0.51-$0.55 Vs $0.57 Est
Business Outlook:
Extreme's business outlook is based on current expectations. The following statements are forward-looking, and actual results could differ materially based on various factors,
Extreme Networks Expects Q4 Revenue of $250.0M-$260.0M Vs $271.21M Est, Adj EPS of $0.11-$0.15 Vs $0.15 Est
Business Outlook:
Extreme's business outlook is based on current expectations. The following statements are forward-looking, and actual results could differ materially based on various factors,
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.